Sales of listed pharmaceutical companies increased 11.5% in average, stating “We overcame the En Bloc Drug Price Reduction”

As sales of listed pharmaceutical companies increased 10% up last year, it is analyzed that they overcame hardships of the En Bloc Drug Price Reduction striking the pharmaceutical industry in 2012.

According to the YakupDotComp’s analysis result of performance results of KOSPI and KOSDAQ listed pharmaceutical companies finalized on December 2014, it is observed that sales increased 11.5% compa...